Deep Dive

Protein Degraders Data Explorer, Q3 2026: BTK Is Next in Line

Degraders have proven themselves at ER and the IMiD targets, and BTK is the only new target in reach of an approval through 2027. This is the interactive data behind our Protein Degraders Intelligence Report, Q3 2026, as of September 2026. Click any chart, card, or row to see what sits behind it.

Deep Dive

Protein Degraders Data Explorer, Q3 2026: BTK Is Next in Line

Degraders have proven themselves at ER and the IMiD targets, and BTK is the only new target in reach of an approval through 2027. This is the interactive data behind our Protein Degraders Intelligence Report, Q3 2026, as of September 2026. Click any chart, card, or row to see what sits behind it.

This is the interactive data explorer for ourProtein Degraders Intelligence Report, Q3 2026.

Protein Degraders Data Explorer, Q3 2026: BTK Is Next in Line

No GatingProtein Degraders Data Explorer, Q3 2026: BTK Is Next in Line
Download

Run this analysis on your own question

Every finding here came from Sleuth’s knowledge base. Bring your own asset, target, or indication, and Sleuth builds the analysis for you.